Galectin Therapeutics
GALT
#8297
Rank
NZ$0.56 B
Marketcap
NZ$5.61
Share price
-5.62%
Change (1 day)
-36.62%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2026 (TTM): NZ-$0.81

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$0.83. In 2025 the company made an earnings per share (EPS) of NZ-$0.84 an increase over its 2024 EPS that were of NZ-$1.34.

EPS history for Galectin Therapeutics from 2001 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.81-4.39%
2025NZ-$0.84-36.84%
2024NZ-$1.342.7%
2023NZ-$1.3013.85%
2022NZ-$1.1425%
2021NZ-$0.9126.83%
2020NZ-$0.725.13%
2019NZ-$0.692.63%
2018NZ-$0.67-22.45%
2017NZ-$0.86-35.53%
2016NZ-$1.34-13.64%
2015NZ-$1.5512.82%
2014NZ-$1.37-40%
2013NZ-$2.2980.56%
2012NZ-$1.27-32.08%
2011NZ-$1.8613.98%
2010NZ-$1.64-22.5%
2009NZ-$2.11185.71%
2008NZ-$0.74-70.83%
2007NZ-$2.53118.18%
2006NZ-$1.16-54.17%
2005NZ-$2.53-14.29%
2004NZ-$2.9547.37%
2003NZ-$2.00-13.64%
2002NZ-$2.32-24.14%
2001NZ-$3.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Mirati Therapeutics
MRTX
NZ-$21.49 2,500.00%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ-$0.23-72.34%๐Ÿ‡บ๐Ÿ‡ธ USA